I share three key lessons for building portfolios, encouraging readers to question popular dividend and valuation approaches.

Last Sunday, Goldman Sachs published new coverage on QuantumScape and reiterated a sell rating on the stock. While Goldman's ...

If you're looking to put cash into two fantastic biotech stocks that Wall Street seems particularly bullish on, there's one ...